Breaking News, Collaborations & Alliances

Evotec, Roche Ink Biomarker Onco-Pact

Three-year deal covers development-stage cancer drugs, may lead to companion diagnostics

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Evotec and Roche have launched a collaboration in novel protein-activity based biomarkers for Roche’s development-stage oncology drugs. Evotec will employ its PhosphoScout platform to discover protein-phosphorylations that predict favorable dosage and efficacy of targeted cancer drugs in patients. Roche will be responsible for conducting clinical trials as well as assessing the development of companion diagnostics for patient stratification. “We are very pleased to collaborate with ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters